Xconomy

JANUARY 24, 2017

One of the nation’s major health insurers has placed limitations on access to the first-ever approved drug for the rare spinal muscular atrophy, validating patient fears that the high price tag of the drug, nusinersen (Spinraza), might make it hard for some with the disease to get treatment.

Anthem 40

Anthem Pricing San Diego Blogging 40

Both Sides of the Table

JUNE 3, 2010

This was really a fun week at TWiVC because we decided to have an entrepreneur come and talk about raising capital rather than having a VC come on. Raised angel money from Rob Lord, Reid Hoffman, Benchmark Capital and others. Current round: $8.1mm in Series C by S3 Ventures (lead), Adams Capital Mgmt, Triangle Peak Partners.

Venture Capital 214

Venture Capital Startup Design S3 214

Both Sides of the Table

JUNE 18, 2010

What a pleasure that I got to spend an hour talking with both Om Malik (whom I’ve always respected his views) and Paul Jozefak , a venture capital partner at Neuhaus Partners in Germany (and formerly the head of Europe for SAP Ventures). Current round: $5.0mm in Series A by NEA and Anthem Venture Partners. Total raised: $5.0mm.

Venture Capital 225

Venture Capital Google Web Sites 225